Dr. Marc Flajolet is Acting Director of the Zachary and Elizabeth M. Fisher Center for Research on Alzheimer’s Disease at

Dr. Barnea, in collaboration with Dr. Roussarie, is responsible for the design of several protocols to modify genetically cultured human

Dr. Bustos’s research led to the discovery that the phosphorylation of Presenilin 1 regulates the levels of beta-amyloid, which suggests

Dr. Chang is an imaging expert and has a deep knowledge of various state-of-the-art microscopic techniques used at the Fisher

Dr. Ledo’s work focuses on understanding how a specific type of cell (called microglia) participates in the development of Alzheimer’s

Dr. Pulina, in collaboration with Dr. Bustos, is studying the mechanisms underlying autophagy, a biological phenomenon used by the cells

Dr. Roussarie’s project focuses on understanding why only certain types of neurons in specific parts of the brain are affected

Dr. Sinha is an experienced synthetic and medicinal chemist. She is working on Gleevec-related projects, creating entirely novel molecules, purifying

Dr. Sinha is an experienced synthetic and medicinal chemist. He oversees all the chemistry projects, including the ones lead by

Dr. Sunkari is the newest member of the Fisher Center. He is a synthetic chemist currently working on Gleevec related

Dr. Xu’s research focuses on deciphering the molecular and biochemical mechanisms by which a protein called GSAP interferes with the

Dr. Netzer’s research focuses on the discovery of molecules and systems within brain cells that can be targeted by drugs

Barry Reisberg, M.D. is a Professor of Psychiatry at NYU Langone Health and Adjunct Professor at the Centre for Studies

The niece of the late Zachary and Elizabeth Fisher, Dr. Kenowsky conducts research at the Fisher Alzheimer’s Disease and Education program at NYU school of Medicine with a goal to change the standard of care for AD patients.